Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Scientific Congress Publications
Supported by Bayer Pharmaceuticals
ISTH 2023
Third Interim Subgroup Analysis of the Effectiveness... (Meijer et al.)
Real-World Effectiveness and Safety of Damoctocog... (Matino et al.)
Value of Hemophilia Drug Treatment Using Analysis... (Berntorp et al.)
Real-world data on patients with hemophilia A switching... (Recht et al.)
Real-world data on patients with hemophilia A with... (Charlet et al.)
Joint range of motion findings among female patients... (Moulton et al.)
© 2024 Bayer. All rights reserved.
Bayer and the Bayer Cross are registered trademarks of Bayer.
Copies of the Bayer Pharmaceuticals supported presentations obtained from this platform are for personal use only and may not be reproduced or distributed without permission from the authors.
Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities, and the presentations are shared in the interest of scientific exchange.
For any questions, please contact Medical Information at https://www.medicalinformation.bayer.com/
PP-GEN-ALL-0006-1
